GAPSS: the Global Anti-Phospholipid Syndrome Score

Sciascia, S., Sanna, G., Murru, V., Roccatello, D., Khamashta, M. A., Bertolaccini, M. L.·2013·Rheumatology
DOI 10.1093/rheumatology/kes388

Cited by (318)

Items 301–318 of 318

  1. Development and initial content validation of a new version of the damage index in thrombotic antiphospholipid syndrome (DIAPSV2)
    María Victoria Goycochea Robles, Gabriela Medina, Claudia Mendoza Pinto, Claudia Meléndez Mercado, Laura-Aline Martínez-Martínez, Pamela Medina San Millán, Silvia Guzmán Vázquez, Aurora Angélica Pérez Ruiz, Mary‐Carmen Amigo · 2025 · Lupus
  2. Impact of antiphospholipid and antinuclear antibodies in coronary artery disease progression
    Tamara García Camarero, Víctor Manuel Martínez-Taboada, Juan Irure‐Ventura, José M. de la Torre Hernández, Alejandra Comins‐Boo, Marcos López‐Hoyos, José L. Hernández · 2025 · Frontiers in Immunology
  3. New ACR/EULAR 2023 classification criteria for antiphospholipid syndrome, what should a gynaecologist know in 2025
    Anne Murarasu, G. Martin de Frémont, G. Guettrot-Imbert, Nathalie Morel, E. Pannier, Adriana Costin-Mihai, Nathalie Costedoat-Chalumeau, Véronique Le Guern · 2025 · Journal of Gynecology Obstetrics and Human Reproduction
  4. Anticoagulation Management of Patients with Antiphospholipid Syndrome Undergoing Cardiopulmonary Bypass in Cardiac Surgery: Challenges and Current Strategies
    Siqi Jiao, Shujie Yan, Yang Zhang, Yuan Teng, Gang Liu, Zhenzhen Li, Zhou Zhou, Bingyang Ji · 2026 · Seminars in Thrombosis and Hemostasis
  5. Antiphospholipid syndrome and pregnancy—a hematologic perspective
    Andrew J. Doyle, Catrin Cox, Karen A. Breen · 2026 · Research and Practice in Thrombosis and Haemostasis
  6. Antiphospholipid antibodies among hospitalized patients predict mortality and readmission: A real-world 10-years cohort study
    Soad Haj Yahia, Hadas Lazarov, Stanely Niznik, Ronen Shavit, Aharon Lubetsky, Nancy Agmon-Levin · 2026 · The American Journal of Medicine
  7. ANA fluorescence patterns and low C4 are associated with higher antiphospholipid antibody serological intensity in routine diagnostic testing
    Nikolaos E. M. Androulakis, Olga Striligka, Eleni Nioti, Antonios Dilintas, Aikaterini Darivianaki, Anastasia Papadopoulou, Fotini Nistikaki, Theodosia Iatridi, Marilena Kampa, Christina H. Kalpadakis · 2026 · Clinical Chemistry and Laboratory Medicine (CCLM)
  8. Antiphospholipid Antibodies and Syndrome
    Andrew J. Doyle, Karen A. Breen, Beverley Jane Hunt · 2026 · Springer eBooks
  9. Cytokine profiling reveals distinct inflammatory clusters and clinical correlations in antiphospholipid syndrome
    Xiangjun Liu, X Chen, Lei Zhu, Liu R, Shirong Dai, Yunshan Zhou, J Z Guo, C Li, Yuzhou Gan, Y P Jia · 2026 · Clinical Rheumatology
  10. Concordance and Relative Performance of the 2023 ACR/EULAR and Revised Sapporo Criteria in Antiphospholipid Syndrome and Analysis of Risk Factors for Recurrent Thrombosis: A Single-Center Cohort Study
    M. Baltaci, Emine Gözde Aydemir Gülöksüz, Ruveyda Sak, Ayşe Tuğçenur Temiz Gençoğlu, Gülnur Çelik, Enver Caner Ceran, Samet DAL, Tugce Elmali Yazli, Recep Yılmaz, Asli Ciftci et al. · 2026 · Medicina
  11. Cardiovascular risk in systemic lupus erythematosus: beyond Framingham to emerging risk prediction tools and therapeutic approaches
    Mona Aflaki, Joanne M. Bargman · 2026 · Frontiers in Lupus
  12. Upadacitinib enhances platelet procoagulant responses in a subset of healthy individuals and patients with SLE: a pilot study
    Veronica Tsegai, Halimat O. Lawal, Cini Mathew John, Ibukun Dorcas Akinrinade, Stella Duncan, Antoine Dufour, Claire E H Barber, Glen Stewart Hazlewood, May Y. Choi, Ejaife O. Agbani · 2026 · Lupus Science & Medicine
  13. Severe thrombocytopenia is associated with arterial thrombotic manifestations in antiphospholipid syndrome: a two-center cohort study
    Jie Kong, Yijing Su, Xinyun Zhu, Jingjing Zhao, Haojie Chen, Xiaoxiang Chen, Yingying Gao · 2026 · Frontiers in Immunology
  14. Clinical relevance of antiphosphatidylserine/prothrombin antibodies in antiphospholipid syndrome
    María Laura Bertolaccini, Giovanni Sanna · 2026 · Current Opinion in Immunology
  15. The predictive value of aGAPSS score combined with clinical factors for thrombosis in systemic lupus erythematosus
    Juan Shi, Libo Ouyang, Qiong Ma, Peiming Zheng · 2026 · Frontiers in Cellular and Infection Microbiology
  16. Association of serum levels of galectin-9 and IP-10 with disease activation in lupus nephritis
    Sibel Varelci, Suzan Çınar, Erdem Gürel, Şafak Mirioğlu, Ömer Uludağ, Ege Sinan Torun, Yasemin Yalçınkaya, Ahmet Gül, Murat İnanç, Bahar Artım-Esen · 2026 · Lupus
  17. Primary antiphospholipid syndrome: emerging strategies and current limitations in diagnosis and management
    Miguel Martins, Ana Rita Cruz-Machado, Sofia Carvalho Barreira, Alice Barinotti, Massimo Radin, Savino Sciascia · 2026 · Future Rare Diseases
  18. Differences in the clinical profile between isolated lupus anticoagulant and triplepositive antiphospholipid antibody profiles in primary antiphospholipid syndrome
    Bruno Verza Azevedo, Flávio Signorelli, Gustavo Guimarães Moreira Balbi, DANIELI CASTRO OLIVEIRA DE ANDRADE · 2026 · Einstein (São Paulo)